Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Data-Driven Prediction Tools Designed for PET/CT

By MedImaging International staff writers
Posted on 21 Jul 2010
Unplanned downtime from clinical equipment can negatively affect virtually every aspect of care delivery--from patient to staff productivity and cost control. More...
A new application utilizes data-driven prediction tools to monitor specific system components. Originally deployed on GE's computed tomography (CT) and interventional cardiovascular imaging systems, the technology is now being used in nuclear medicine and positron emission tomography (PET)/CT to proactively monitor system performance, alert GE field engineers to variations in specific component performance, and forecast maintenance needs to enable the least amount of disruption to operations.

GE Healthcare (Chalfont St. Giles, UK), a unit of General Electric (Fairfield, CT, USA), introduced InSite OnWatch, a feature of GE's AssurePoint Services product range, at the Society of Nuclear Medicine (SNM) 2010 annual meeting in Salt Lake City, UT, USA, June 5-9, 2010. InSite OnWatch, available only with GE's AssurePoint Rapid and AssurePoint Performance service offerings (USA and Canada only), remotely resolves small performance issues and forecasts maintenance on certain larger issues to reduce unplanned downtime--improving efficiencies and helping to lower the cost of care. InSite OnWatch is now available on GE's Discovery NM 530c, the Discovery NM/CT 570c and the Discovery PET/CT 600 series systems with the new Discovery Dimension console.

AssurePoint Services are backed by a network of more than 3,500 local field engineers as well as dedicated remote online engineers with deep industry and technology expertise to deliver fast, professional response when it is needed. "The addition of InSite OnWatch to GE's leading AssurePoint Service platform helps minimize the risk of having to reschedule patients and allows customers to schedule required maintenance around their schedule, minimizing unplanned downtime,” said Mike Swinford, vice president and general manager, Americas Service. "Introducing InSite OnWatch to the nuclear medicine and PET/CT communities will only enhance our proven performance-- providing exceptional service to improve system workflow and overall patient care.”

Related Links:

GE Healthcare







Ultrasound Table
Women’s Ultrasound EA Table
Diagnostic Ultrasound System
DC-80A
Portable X-ray Unit
AJEX140H
Post-Processing Imaging System
DynaCAD Prostate
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to MedImaging.net and get access to news and events that shape the world of Radiology.
  • Free digital version edition of Medical Imaging International sent by email on regular basis
  • Free print version of Medical Imaging International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of Medical Imaging International in digital format
  • Free Medical Imaging International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Nuclear Medicine

view channel
Image: This artistic representation illustrates how the drug candidate NECT-224 works in the human body (Photo courtesy of HZDR/A. Gruetzner)

Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies

Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.